Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Response to PD-1 inhibitor after progression on PD-L1 inhibitor in advanced HCC.
Journal: BMJ case reports
Published: August 12, 2022
Treatment of Metastatic Disease with Immune Checkpoint Inhibitors Nivolumab and Pembrolizumab: Effect of Performance Status on Clinical Outcomes.
Journal: Journal of immunotherapy and precision oncology
Published: January 07, 2022
Association of Homologous Recombination-DNA Damage Response Gene Mutations with Immune Biomarkers in Gastroesophageal Cancers.
Journal: Molecular cancer therapeutics
Published: October 18, 2020
Combination of pan-RAF and MEK inhibitors in NRAS mutant melanoma.
Journal: Molecular cancer
Published: October 24, 2014
Effects of MAPK and PI3K pathways on PD-L1 expression in melanoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 09, 2014
Effects of AKT inhibitor therapy in response and resistance to BRAF inhibition in melanoma.
Journal: Molecular cancer
Published: September 25, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026